THERIOSOL

Indicaton

antibiotic replacement with blend of natural molecules. No phenotype resistance

Therapeutic indications

Infectious disease

Type of product

Small molecule

Table

Phase

Phase I completed
Available in

France

You may also be interested in

OligoPhore / SemaPhore / CycloPhore Peptide-Based RNA Delivery Platforms

Delivers siRNA, antisense oligonucleotides, linear or circular mRNA and other RNA modalities to extrahepatic tissues - demonstrated across various indications in oncology (e.g. PDAC, breast cancer, ovarian cancer, lung cancer, melanoma, ATLL, TME), and inflammatory / autoimmune diseases (e.g. OA, RA, enterocolitis), CV (e.g. atherosclerosis, aortic aneurysm)

Discovery

Cadazolid

Crohn's disease

Phase II started

Cresemba (isavuconazole)

Invasive aspergillosis and mucormycosis

Marketed